SR750 tablet

DRUG4 trials

Sponsors

Shanghai SIMR Biotechnology Co., Ltd.

Conditions

HealthyHealthy VolunteersTrigeminal Neuralgia

Phase 1

The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers

CompletedNCT05083468

Shanghai SIMR Biotechnology Co., Ltd.Healthy Volunteers

Start: 2021-10-29End: 2022-10-14Updated: 2024-11-29

The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers

CompletedNCT05753033

Shanghai SIMR Biotechnology Co., Ltd.Healthy

Start: 2023-02-28End: 2023-09-06Updated: 2024-11-29

The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers

CompletedNCT06932536

Shanghai SIMR Biotechnology Co., Ltd.Healthy

Start: 2025-04-28End: 2025-07-07Updated: 2025-12-31

Phase 2

Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia

CompletedNCT06571448

Shanghai SIMR Biotechnology Co., Ltd.Trigeminal Neuralgia

Start: 2024-09-16End: 2026-02-24Updated: 2026-04-24